Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Acrux Limited ( (AU:ACR) ) has shared an update.
Acrux Limited has announced a change in its director’s interests, with Michael Kotsanis acquiring 857,142 free attaching options. This issuance of options, approved at the recent Extraordinary General Meeting, reflects the company’s ongoing efforts to align management incentives with shareholder interests and may influence the company’s strategic direction.
More about Acrux Limited
Acrux Limited operates in the pharmaceutical industry, focusing on the development and commercialization of specialty topical and transdermal products.
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $8.24M
See more insights into ACR stock on TipRanks’ Stock Analysis page.
